# Jaimin Patel, M.D. – FDA Inspection, Oct 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/jaimin-patel-md/c02f059b-8c49-43a2-88cd-89fba18507c6
Source feed: FDA_Inspections

> FDA inspection 1255618 of Jaimin Patel, M.D., October 18, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255618
- Company Name: Jaimin Patel, M.D.
- Inspection Date: 2024-10-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gene-r-gunn/3c011052-9264-461e-a92e-4af3cc26819c)

Company: https://www.keypedia.com/companies/jaimin-patel-md/8b58edfc-d4b0-49e9-ac58-f8b1e0c02693

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c